Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

To examine the possible involvement of human B cell leukemia/lymphoma 2 (Bcl-2), CD4+ cells, hepatocyte growth factor (HGF), and metalloproteinase-9 (MMP-9), as biomarkers in early diagnosis of hepatocellular carcinoma (HCC), activities of these biomarkers in serum were demonstrated by the method of Enzyme Linked Immunosorbant Assay. Two groups of subjects (60 for each), were examined in this study; healthy controls and patients with HCC. The present results declare that, significant decrease in Bcl-2 (p ≤ 0.0001), and CD 4+ (p ≤ 0.001), while significant increase in HGF and MMP-9 (p ≤ 0.05). These findings imply an influence of these biomarkers by the existence of hepatic carcinoma that might reflect the progression of disease and a distinction between the pathological mechanisms involved in hepatic carcinoma. Since, the serum MMP-9 activity was significantly varied between each stage of HCC. An individual profile of the present investigated parameters was detected that might serve as an easy accessing serum marker to monitor the progression of hepatic cell disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–16.

    Article  PubMed  Google Scholar 

  2. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48:1312–27.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Lee JS, Thorgeirsson SS. Comparative and integrative functional genomics of HCC. Oncogene. 2006;25:3801–9.

    Article  CAS  PubMed  Google Scholar 

  4. Frau M, Biasi F, Feo F, Pascale RM. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. Mol Aspects Med. 2010;31:179–93.

    Article  CAS  PubMed  Google Scholar 

  5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Shih T-C, Tien Y-J, Wen C-J, Yeh T-S, Ming-Chin Y, Huang C-H, Lee Y-S, Yen T-C, Hsieh S-Y. MicroRNA-214 down regulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol. 2012;57:584–91.

    Article  CAS  PubMed  Google Scholar 

  7. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. EJSO. 2007;33:208–12.

    Article  PubMed  Google Scholar 

  8. Mazzanti R, Platini F, Bottini C, Fantappie O, Solazzo M, Tessitore L. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Biochem Pharmacol. 2009;78:21–32.

    Article  CAS  PubMed  Google Scholar 

  9. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev. 2007;6:304–12.

    CAS  Google Scholar 

  10. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Investig. 2003;112:1809–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Canuto RA, Tessitore L, Muzio G, Autelli R, Baccino FM. Tissue protein turnover during liver carcinogenesis. Carcinogenesis. 1993;14:2581–7.

    Article  CAS  PubMed  Google Scholar 

  12. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol. 2007;9:218–24.

    Article  CAS  PubMed  Google Scholar 

  13. Narayanan BA, Condon MS, Bosland MC, Narayanan NK, Reddy BS. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s). Clin Cancer Res. 2003;9:3503–13.

    CAS  PubMed  Google Scholar 

  14. Zhang GS, Liu DS, Dai CW, Li RJ. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and down regulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Am J Hematol. 2006;81(4):242–55.

    Article  CAS  PubMed  Google Scholar 

  15. Roberto M, Francesca P, Consuelo B, Ornella F, Michela S, Luciana T. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Biochem Pharmacol. 2009;78:21–32.

    Article  Google Scholar 

  16. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122:927–39.

    Article  CAS  PubMed  Google Scholar 

  17. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010;29:4989–5005.

    Article  CAS  PubMed  Google Scholar 

  18. Tan S, Li R, Ding K, Lobie PE, Zhu T. miR-198 inhibits migration and invasion of hepatoce by targeting the HGF/c-MET pathway. FEBS Lett. 2011;585:2229–34.

    Article  CAS  PubMed  Google Scholar 

  19. Yamagamim H, Moriyama M, Matsumura H. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer. 2002;95:824–34.

    Article  CAS  PubMed  Google Scholar 

  20. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998;27:407–14.

    Article  CAS  PubMed  Google Scholar 

  21. Parmiani G, Anichini AT. Cell infiltration and prognosis in HCC patients. J Hepatol. 2006;45:178–81.

    Article  PubMed  Google Scholar 

  22. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–700.

    Article  CAS  PubMed  Google Scholar 

  23. Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood. 2006;107:3639–46.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L. Foxp3 expressing CD4+ CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 2004;173:1444–53.

    Article  CAS  PubMed  Google Scholar 

  25. Parmiani G. Tumor-infiltrating T cells—friend or foe of neoplastic cells? New Engl J Med. 2005;353:2640–41.

    Google Scholar 

  26. Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol. 2006;45:254–62.

    Article  CAS  PubMed  Google Scholar 

  27. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G. Regulatory CD4+ CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 2001;61:4766–72.

    CAS  PubMed  Google Scholar 

  28. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168:4272–6.

    Article  CAS  PubMed  Google Scholar 

  29. Cureil TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–9.

    Article  Google Scholar 

  30. Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005;41:722–30.

    Article  CAS  PubMed  Google Scholar 

  31. Harada T, Arii S, Mise M, Imamura T, Higashitsuji H, Furutani M, Niwano M, Ishigami S, Fukumoto M, Eiki M, Sato H, Imamura M. Membrane-type matrix metalloproteinase-1(MT1-MMP) gene isoverexpressed in highly invasive hepatocellular carcinomas. J Hepatol. 1998;28:231–9.

    Article  CAS  PubMed  Google Scholar 

  32. Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Gene. 2013;517:65–71.

    Article  CAS  PubMed  Google Scholar 

  33. Nakajima M, Welch DR, Wynn DM, Tsuruo T, Nicolson GL. Serum and plasma M(r) 92000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res. 1993;53:5802–7.

    CAS  PubMed  Google Scholar 

  34. Hamdy FC, Fadlon EJ, Cottam D, Lawry J, Thurrel W, Silcocks PB, et al. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer. 1994;69:177–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer. 1994;58:50–6.

    Article  CAS  PubMed  Google Scholar 

  36. Yamamoto H, Itoh F, Adachi Y, Sakamoto H, Adachi M, Hinoda Y, et al. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepato-cellular carcinoma. Gastroenterology. 1997;112:1290.

    Article  CAS  PubMed  Google Scholar 

  37. Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M. Overexpression of matrix metalloproteinase-9 genein hepatocellular carcinoma with invasive potential. Hepatology. 1996;24:316–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Biochemistry Department, National Research Center, Dokki, Giza, Egypt

    Eman R. Youness, F. S. Oraby & Nadia M. Ahmed

  2. Internal Medicine Department, 6 October University, Cairo, Egypt

    Mohamed El Nemr

  3. Internal Medicine Department, Ain Shams University, Cairo, Egypt

    Mohamed A. Moghni

  4. Therapeutic Chemistry Department, National Research Center, Dokki, Giza, Egypt

    Hanan F. Aly

  5. Hormones Department, National Research Center, Dokki, Giza, Egypt

    Hanaa H. Ahmed

Authors
  1. Eman R. Youness
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed El Nemr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. S. Oraby
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nadia M. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohamed A. Moghni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hanan F. Aly
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hanaa H. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanan F. Aly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Youness, E.R., El Nemr, M., Oraby, F.S. et al. Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma. Ind J Clin Biochem 29, 351–356 (2014). https://doi.org/10.1007/s12291-013-0381-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-013-0381-5

Keywords

Search

Navigation